rs2279199

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The ENST00000683807.1(ENSG00000288713):​n.18A>G variant causes a non coding transcript exon change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.461 in 1,597,468 control chromosomes in the GnomAD database, including 171,506 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.45 ( 15447 hom., cov: 33)
Exomes 𝑓: 0.46 ( 156059 hom. )

Consequence

ENSG00000288713
ENST00000683807.1 non_coding_transcript_exon

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:3O:1

Conservation

PhyloP100: 0.0250

Publications

27 publications found
Variant links:
Genes affected
UMPS (HGNC:12563): (uridine monophosphate synthetase) This gene encodes a uridine 5'-monophosphate synthase. The encoded protein is a bifunctional enzyme that catalyzes the final two steps of the de novo pyrimidine biosynthetic pathway. The first reaction is carried out by the N-terminal enzyme orotate phosphoribosyltransferase which converts orotic acid to orotidine-5'-monophosphate. The terminal reaction is carried out by the C-terminal enzyme OMP decarboxylase which converts orotidine-5'-monophosphate to uridine monophosphate. Defects in this gene are the cause of hereditary orotic aciduria. Alternate splicing results in multiple transcript variants. [provided by RefSeq, Mar 2010]
UMPS Gene-Disease associations (from GenCC):
  • orotic aciduria
    Inheritance: AR, AD Classification: DEFINITIVE, STRONG, MODERATE, SUPPORTIVE Submitted by: Orphanet, G2P, Ambry Genetics, Labcorp Genetics (formerly Invitae)

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.8).
BP6
Variant 3-124730405-T-C is Benign according to our data. Variant chr3-124730405-T-C is described in ClinVar as Benign. ClinVar VariationId is 100125.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.565 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: ENST00000683807.1. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
UMPS
NM_000373.4
MANE Select
c.-67T>C
upstream_gene
N/ANP_000364.1
UMPS
NR_033434.2
n.-47T>C
upstream_gene
N/A
UMPS
NR_033437.2
n.-47T>C
upstream_gene
N/A

Ensembl Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
ENSG00000288713
ENST00000683807.1
n.18A>G
non_coding_transcript_exon
Exon 1 of 3
UMPS
ENST00000232607.7
TSL:1 MANE Select
c.-67T>C
upstream_gene
N/AENSP00000232607.2
UMPS
ENST00000460034.5
TSL:1
n.-67T>C
upstream_gene
N/AENSP00000420409.1

Frequencies

GnomAD3 genomes
AF:
0.446
AC:
67687
AN:
151870
Hom.:
15439
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.365
Gnomad AMI
AF:
0.382
Gnomad AMR
AF:
0.555
Gnomad ASJ
AF:
0.515
Gnomad EAS
AF:
0.583
Gnomad SAS
AF:
0.438
Gnomad FIN
AF:
0.426
Gnomad MID
AF:
0.494
Gnomad NFE
AF:
0.459
Gnomad OTH
AF:
0.470
GnomAD2 exomes
AF:
0.497
AC:
119695
AN:
240742
AF XY:
0.491
show subpopulations
Gnomad AFR exome
AF:
0.358
Gnomad AMR exome
AF:
0.655
Gnomad ASJ exome
AF:
0.522
Gnomad EAS exome
AF:
0.610
Gnomad FIN exome
AF:
0.456
Gnomad NFE exome
AF:
0.466
Gnomad OTH exome
AF:
0.497
GnomAD4 exome
AF:
0.462
AC:
668105
AN:
1445480
Hom.:
156059
Cov.:
29
AF XY:
0.461
AC XY:
331350
AN XY:
718548
show subpopulations
African (AFR)
AF:
0.357
AC:
11877
AN:
33228
American (AMR)
AF:
0.642
AC:
28508
AN:
44432
Ashkenazi Jewish (ASJ)
AF:
0.515
AC:
13274
AN:
25790
East Asian (EAS)
AF:
0.567
AC:
22399
AN:
39518
South Asian (SAS)
AF:
0.440
AC:
37528
AN:
85258
European-Finnish (FIN)
AF:
0.432
AC:
21972
AN:
50846
Middle Eastern (MID)
AF:
0.482
AC:
2068
AN:
4292
European-Non Finnish (NFE)
AF:
0.456
AC:
502868
AN:
1102398
Other (OTH)
AF:
0.462
AC:
27611
AN:
59718
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.478
Heterozygous variant carriers
0
16161
32322
48482
64643
80804
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
15150
30300
45450
60600
75750
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.446
AC:
67735
AN:
151988
Hom.:
15447
Cov.:
33
AF XY:
0.448
AC XY:
33273
AN XY:
74296
show subpopulations
African (AFR)
AF:
0.365
AC:
15136
AN:
41426
American (AMR)
AF:
0.555
AC:
8491
AN:
15288
Ashkenazi Jewish (ASJ)
AF:
0.515
AC:
1787
AN:
3470
East Asian (EAS)
AF:
0.583
AC:
3007
AN:
5160
South Asian (SAS)
AF:
0.437
AC:
2100
AN:
4802
European-Finnish (FIN)
AF:
0.426
AC:
4498
AN:
10564
Middle Eastern (MID)
AF:
0.493
AC:
145
AN:
294
European-Non Finnish (NFE)
AF:
0.459
AC:
31228
AN:
67962
Other (OTH)
AF:
0.471
AC:
995
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.511
Heterozygous variant carriers
0
1956
3911
5867
7822
9778
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
628
1256
1884
2512
3140
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.467
Hom.:
3721
Bravo
AF:
0.456
Asia WGS
AF:
0.488
AC:
1695
AN:
3478

ClinVar

Significance: Benign
Submissions summary: Benign:3Other:1
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:2Other:1
Jun 19, 2021
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Diasio Lab, Mayo Clinic
Significance:not provided
Review Status:no classification provided
Collection Method:literature only

Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

Oroticaciduria Benign:1
Jun 14, 2016
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.80
CADD
Benign
5.2
DANN
Benign
0.55
PhyloP100
0.025
PromoterAI
-0.032
Neutral
Mutation Taster
=300/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs2279199; hg19: chr3-124449252; COSMIC: COSV51736861; COSMIC: COSV51736861; API